Product Details
| Product Name: Erlotinib hydrochloride | CAS No.: 183319-69-9 |
| EC-No.: 620-491-0 | Min. Order: 100g |
| Purity: 99 | Supply Ability: 10kg |
| Release date: 2025/12/03 |
Erlotinib hydrochlorate is a small molecule tyrosine kinase inhibitor which acts reversibly on epidermal growth factor receptors, a hydrochloride of erlotinib, a molecular-targeted drug. The US Food and Drug Administration (FDA) has approved erlotinib (Tarceva) combined with gemcitabine as a first-line treatment for locally advanced and metastatic pancreatic cancer.
Company Profile Introduction
-
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $35.00/50mg |
VIP4Y
|
TargetMol Chemicals Inc.
|
2026-01-13 | |
| $35.00/50mg |
VIP6Y
|
TargetMol Chemicals Inc.
|
2026-01-13 | |
| $35.00/50mg |
VIP2Y
|
TargetMol Chemicals Inc.
|
2025-04-30 | |
| $/ |
VIP5Y
|
RongNa Biotechnology Co.,Ltd
|
2025-04-29 | |
| $0.00/1kg |
VIP5Y
|
Sinoway Industrial co., ltd.
|
2024-12-26 | |
| $0.00/1g |
HangZhou RunYan Pharma Technology Co.,LTD.
|
2024-11-19 | ||
| $0.00/1KG |
Hebei Chuanghai Biotechnology Co., Ltd
|
2024-10-29 | ||
| $0.00/1g |
VIP2Y
|
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
|
2024-08-02 | |
| $1.00/1g |
Apeloa production Co.,Limited
|
2024-06-19 | ||
| $0.00/1kg |
VIP2Y
|
Shaanxi TNJONE Pharmaceutical Co., Ltd
|
2024-05-13 |
China- Since: 2018-09-06
- Address: B801, Jintai District, Baoji City, Shaanxi Province, China, Dongling Financial Plaza, Jintai Distric
INQUIRY
YANG
13892490616
gksales1@gk-bio.com
13892490616
gksales1@gk-bio.com